Postsynaptic α-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior

Han Ting Zhang, Lisa R. Whisler, Ying Huang, Yang Kevin Xiang, James M. O'Donnell

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The antidepressant desipramine inhibits the reuptake of norepinephrine (NE), leading to activation of both pre- and postsynaptic adrenergic receptors, including α-1, α-2, β-1, and β-2 subtypes. However, it is not clear which adrenergic receptors are involved in mediating its antidepressant effects. Treatment of mice with desipramine (20 mg/kg, i.p.) produced an antidepressant-like effect, as evidenced by decreased immobility in the forced-swim test; this was antagonized by pretreatment with the α-2 adrenergic antagonist idazoxan (0.1-2.5 mg/kg, i.p.). Similarly, idazoxan, administered peripherally (0.5-2.5 mg/kg, i.p.) or centrally (1-10 μg, i.c.v.), antagonized the antidepressant-like effect of desipramine in rats responding under a differential-reinforcement-of-low-rate (DRL) 72-s schedule, ie, decreased response rate and increased reinforcement rate. By contrast, pretreatment with the β-adrenergic antagonists propranolol and CGP-12177 or the α-1 adrenergic antagonist prazosin did not alter the antidepressant-like effect of desipramine on DRL behavior. The lack of involvement of β-adrenergic receptors in mediating the behavioral effects of desipramine was confirmed using knockout lines. In the forced-swim test, the desipramine-induced decrease in immobility was not altered in mice deficient in β-1, β-2, or both β-1 and β-2 adrenergic receptors. In addition, desipramine (3-30 mg/kg) produced an antidepressant-like effect on behavior under a DRL 36-s schedule in mice deficient in both β-1 and β-2 adrenergic receptors. As antagonism of presynaptic α-2 adrenergic receptors facilitates NE release, which potentiates the effects of desipramine, the present results suggest that postsynaptic α-2 adrenergic receptors play an important role in its antidepressant effects.

Original languageEnglish (US)
Pages (from-to)1067-1077
Number of pages11
JournalNeuropsychopharmacology
Volume34
Issue number4
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Desipramine
Adrenergic Receptors
Antidepressive Agents
Adrenergic Antagonists
Idazoxan
Norepinephrine
Appointments and Schedules
Prazosin
Propranolol
Reinforcement (Psychology)

Keywords

  • α-2 adrenergic receptors
  • β-adrenergic receptors
  • Antidepressant
  • Desipramine
  • DRL behavior
  • Forced-swim behavior

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Postsynaptic α-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. / Zhang, Han Ting; Whisler, Lisa R.; Huang, Ying; Xiang, Yang Kevin; O'Donnell, James M.

In: Neuropsychopharmacology, Vol. 34, No. 4, 03.2009, p. 1067-1077.

Research output: Contribution to journalArticle

Zhang, Han Ting ; Whisler, Lisa R. ; Huang, Ying ; Xiang, Yang Kevin ; O'Donnell, James M. / Postsynaptic α-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. In: Neuropsychopharmacology. 2009 ; Vol. 34, No. 4. pp. 1067-1077.
@article{58835802e2094f039e8a3ea27254cd82,
title = "Postsynaptic α-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior",
abstract = "The antidepressant desipramine inhibits the reuptake of norepinephrine (NE), leading to activation of both pre- and postsynaptic adrenergic receptors, including α-1, α-2, β-1, and β-2 subtypes. However, it is not clear which adrenergic receptors are involved in mediating its antidepressant effects. Treatment of mice with desipramine (20 mg/kg, i.p.) produced an antidepressant-like effect, as evidenced by decreased immobility in the forced-swim test; this was antagonized by pretreatment with the α-2 adrenergic antagonist idazoxan (0.1-2.5 mg/kg, i.p.). Similarly, idazoxan, administered peripherally (0.5-2.5 mg/kg, i.p.) or centrally (1-10 μg, i.c.v.), antagonized the antidepressant-like effect of desipramine in rats responding under a differential-reinforcement-of-low-rate (DRL) 72-s schedule, ie, decreased response rate and increased reinforcement rate. By contrast, pretreatment with the β-adrenergic antagonists propranolol and CGP-12177 or the α-1 adrenergic antagonist prazosin did not alter the antidepressant-like effect of desipramine on DRL behavior. The lack of involvement of β-adrenergic receptors in mediating the behavioral effects of desipramine was confirmed using knockout lines. In the forced-swim test, the desipramine-induced decrease in immobility was not altered in mice deficient in β-1, β-2, or both β-1 and β-2 adrenergic receptors. In addition, desipramine (3-30 mg/kg) produced an antidepressant-like effect on behavior under a DRL 36-s schedule in mice deficient in both β-1 and β-2 adrenergic receptors. As antagonism of presynaptic α-2 adrenergic receptors facilitates NE release, which potentiates the effects of desipramine, the present results suggest that postsynaptic α-2 adrenergic receptors play an important role in its antidepressant effects.",
keywords = "α-2 adrenergic receptors, β-adrenergic receptors, Antidepressant, Desipramine, DRL behavior, Forced-swim behavior",
author = "Zhang, {Han Ting} and Whisler, {Lisa R.} and Ying Huang and Xiang, {Yang Kevin} and O'Donnell, {James M.}",
year = "2009",
month = "3",
doi = "10.1038/npp.2008.184",
language = "English (US)",
volume = "34",
pages = "1067--1077",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Postsynaptic α-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior

AU - Zhang, Han Ting

AU - Whisler, Lisa R.

AU - Huang, Ying

AU - Xiang, Yang Kevin

AU - O'Donnell, James M.

PY - 2009/3

Y1 - 2009/3

N2 - The antidepressant desipramine inhibits the reuptake of norepinephrine (NE), leading to activation of both pre- and postsynaptic adrenergic receptors, including α-1, α-2, β-1, and β-2 subtypes. However, it is not clear which adrenergic receptors are involved in mediating its antidepressant effects. Treatment of mice with desipramine (20 mg/kg, i.p.) produced an antidepressant-like effect, as evidenced by decreased immobility in the forced-swim test; this was antagonized by pretreatment with the α-2 adrenergic antagonist idazoxan (0.1-2.5 mg/kg, i.p.). Similarly, idazoxan, administered peripherally (0.5-2.5 mg/kg, i.p.) or centrally (1-10 μg, i.c.v.), antagonized the antidepressant-like effect of desipramine in rats responding under a differential-reinforcement-of-low-rate (DRL) 72-s schedule, ie, decreased response rate and increased reinforcement rate. By contrast, pretreatment with the β-adrenergic antagonists propranolol and CGP-12177 or the α-1 adrenergic antagonist prazosin did not alter the antidepressant-like effect of desipramine on DRL behavior. The lack of involvement of β-adrenergic receptors in mediating the behavioral effects of desipramine was confirmed using knockout lines. In the forced-swim test, the desipramine-induced decrease in immobility was not altered in mice deficient in β-1, β-2, or both β-1 and β-2 adrenergic receptors. In addition, desipramine (3-30 mg/kg) produced an antidepressant-like effect on behavior under a DRL 36-s schedule in mice deficient in both β-1 and β-2 adrenergic receptors. As antagonism of presynaptic α-2 adrenergic receptors facilitates NE release, which potentiates the effects of desipramine, the present results suggest that postsynaptic α-2 adrenergic receptors play an important role in its antidepressant effects.

AB - The antidepressant desipramine inhibits the reuptake of norepinephrine (NE), leading to activation of both pre- and postsynaptic adrenergic receptors, including α-1, α-2, β-1, and β-2 subtypes. However, it is not clear which adrenergic receptors are involved in mediating its antidepressant effects. Treatment of mice with desipramine (20 mg/kg, i.p.) produced an antidepressant-like effect, as evidenced by decreased immobility in the forced-swim test; this was antagonized by pretreatment with the α-2 adrenergic antagonist idazoxan (0.1-2.5 mg/kg, i.p.). Similarly, idazoxan, administered peripherally (0.5-2.5 mg/kg, i.p.) or centrally (1-10 μg, i.c.v.), antagonized the antidepressant-like effect of desipramine in rats responding under a differential-reinforcement-of-low-rate (DRL) 72-s schedule, ie, decreased response rate and increased reinforcement rate. By contrast, pretreatment with the β-adrenergic antagonists propranolol and CGP-12177 or the α-1 adrenergic antagonist prazosin did not alter the antidepressant-like effect of desipramine on DRL behavior. The lack of involvement of β-adrenergic receptors in mediating the behavioral effects of desipramine was confirmed using knockout lines. In the forced-swim test, the desipramine-induced decrease in immobility was not altered in mice deficient in β-1, β-2, or both β-1 and β-2 adrenergic receptors. In addition, desipramine (3-30 mg/kg) produced an antidepressant-like effect on behavior under a DRL 36-s schedule in mice deficient in both β-1 and β-2 adrenergic receptors. As antagonism of presynaptic α-2 adrenergic receptors facilitates NE release, which potentiates the effects of desipramine, the present results suggest that postsynaptic α-2 adrenergic receptors play an important role in its antidepressant effects.

KW - α-2 adrenergic receptors

KW - β-adrenergic receptors

KW - Antidepressant

KW - Desipramine

KW - DRL behavior

KW - Forced-swim behavior

UR - http://www.scopus.com/inward/record.url?scp=59949089339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59949089339&partnerID=8YFLogxK

U2 - 10.1038/npp.2008.184

DO - 10.1038/npp.2008.184

M3 - Article

C2 - 18923403

AN - SCOPUS:59949089339

VL - 34

SP - 1067

EP - 1077

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 4

ER -